594 related articles for article (PubMed ID: 12434420)
21. Potential role of the angiopoietin/tie2 system in ischemia-induced retinal neovascularization.
Takagi H; Koyama S; Seike H; Oh H; Otani A; Matsumura M; Honda Y
Invest Ophthalmol Vis Sci; 2003 Jan; 44(1):393-402. PubMed ID: 12506101
[TBL] [Abstract][Full Text] [Related]
22. Transforming growth factor alpha is a target for the von Hippel-Lindau tumor suppressor.
Knebelmann B; Ananth S; Cohen HT; Sukhatme VP
Cancer Res; 1998 Jan; 58(2):226-31. PubMed ID: 9443397
[TBL] [Abstract][Full Text] [Related]
23. Angiopoietins in angiogenesis and beyond.
Tsigkos S; Koutsilieris M; Papapetropoulos A
Expert Opin Investig Drugs; 2003 Jun; 12(6):933-41. PubMed ID: 12783598
[TBL] [Abstract][Full Text] [Related]
24. Hypoxia-inducible factor-1 mediates activation of cultured vascular endothelial cells by inducing multiple angiogenic factors.
Yamakawa M; Liu LX; Date T; Belanger AJ; Vincent KA; Akita GY; Kuriyama T; Cheng SH; Gregory RJ; Jiang C
Circ Res; 2003 Oct; 93(7):664-73. PubMed ID: 12958144
[TBL] [Abstract][Full Text] [Related]
25. NERF2, a member of the Ets family of transcription factors, is increased in response to hypoxia and angiopoietin-1: a potential mechanism for Tie2 regulation during hypoxia.
Christensen RA; Fujikawa K; Madore R; Oettgen P; Varticovski L
J Cell Biochem; 2002; 85(3):505-15. PubMed ID: 11967990
[TBL] [Abstract][Full Text] [Related]
26. Loss of HNF1alpha function in human renal cell carcinoma: frequent mutations in the VHL gene but not the HNF1alpha gene.
Lemm I; Lingott A; Pogge v Strandmann E; Zoidl C; Bulman MP; Hattersley AT; Schulz WA; Ebert T; Ryffel GU
Mol Carcinog; 1999 Apr; 24(4):305-14. PubMed ID: 10326868
[TBL] [Abstract][Full Text] [Related]
27. Detection of circulating cancer cells with von hippel-lindau gene mutation in peripheral blood of patients with renal cell carcinoma.
Ashida S; Okuda H; Chikazawa M; Tanimura M; Sugita O; Yamamoto Y; Nakamura S; Moriyama M; Shuin T
Clin Cancer Res; 2000 Oct; 6(10):3817-22. PubMed ID: 11051223
[TBL] [Abstract][Full Text] [Related]
28. Vascular endothelial growth factor overexpression is correlated with von Hippel-Lindau tumor suppressor gene inactivation in patients with sporadic renal cell carcinoma.
Igarashi H; Esumi M; Ishida H; Okada K
Cancer; 2002 Jul; 95(1):47-53. PubMed ID: 12115316
[TBL] [Abstract][Full Text] [Related]
29. Identification of novel VHL target genes and relationship to hypoxic response pathways.
Maina EN; Morris MR; Zatyka M; Raval RR; Banks RE; Richards FM; Johnson CM; Maher ER
Oncogene; 2005 Jun; 24(28):4549-58. PubMed ID: 15824735
[TBL] [Abstract][Full Text] [Related]
30. Serial analysis of gene expression in renal carcinoma cells reveals VHL-dependent sensitivity to TNFalpha cytotoxicity.
Caldwell MC; Hough C; Fürer S; Linehan WM; Morin PJ; Gorospe M
Oncogene; 2002 Jan; 21(6):929-36. PubMed ID: 11840338
[TBL] [Abstract][Full Text] [Related]
31. Loss of von Hippel-Lindau protein causes cell density dependent deregulation of CyclinD1 expression through hypoxia-inducible factor.
Baba M; Hirai S; Yamada-Okabe H; Hamada K; Tabuchi H; Kobayashi K; Kondo K; Yoshida M; Yamashita A; Kishida T; Nakaigawa N; Nagashima Y; Kubota Y; Yao M; Ohno S
Oncogene; 2003 May; 22(18):2728-38. PubMed ID: 12743597
[TBL] [Abstract][Full Text] [Related]
32. Expression of angiopoietins, Tie2 and vascular endothelial growth factor in angiogenesis and progression of hepatocellular carcinoma.
Zhang ZL; Liu ZS; Sun Q
World J Gastroenterol; 2006 Jul; 12(26):4241-5. PubMed ID: 16830384
[TBL] [Abstract][Full Text] [Related]
33. Tissue expression and plasma levels of adrenomedullin in renal cancer patients.
Michelsen J; Thiesson H; Walter S; Ottosen PD; Skøtt O; Jensen BL
Clin Sci (Lond); 2006 Jul; 111(1):61-70. PubMed ID: 16515534
[TBL] [Abstract][Full Text] [Related]
34. Loss of PL6 protein expression in renal clear cell carcinomas and other VHL-deficient tumours.
Ivanova AV; Vortmeyer A; Ivanov SV; Nickerson ML; Maher ER; Lerman MI
J Pathol; 2008 Jan; 214(1):46-57. PubMed ID: 17973242
[TBL] [Abstract][Full Text] [Related]
35. Allelic deletions of the VHL gene detected in multiple microscopic clear cell renal lesions in von Hippel-Lindau disease patients.
Lubensky IA; Gnarra JR; Bertheau P; Walther MM; Linehan WM; Zhuang Z
Am J Pathol; 1996 Dec; 149(6):2089-94. PubMed ID: 8952541
[TBL] [Abstract][Full Text] [Related]
36. Up-regulation of hypoxia-inducible factor 2alpha in renal cell carcinoma associated with loss of Tsc-2 tumor suppressor gene.
Liu MY; Poellinger L; Walker CL
Cancer Res; 2003 May; 63(10):2675-80. PubMed ID: 12750296
[TBL] [Abstract][Full Text] [Related]
37. Regulation of E2F1 by the von Hippel-Lindau tumour suppressor protein predicts survival in renal cell cancer patients.
Mans DA; Vermaat JS; Weijts BG; van Rooijen E; van Reeuwijk J; Boldt K; Daenen LG; van der Groep P; Rowland BD; Jans JJ; Roepman R; Voest EE; van Diest PJ; Verhaar MC; de Bruin A; Giles RH
J Pathol; 2013 Sep; 231(1):117-29. PubMed ID: 23744542
[TBL] [Abstract][Full Text] [Related]
38. Cyclical mechanical stretch enhances angiopoietin-2 and Tie2 receptor expression in cultured human umbilical vein endothelial cells.
Chang H; Wang BW; Kuan P; Shyu KG
Clin Sci (Lond); 2003 Apr; 104(4):421-8. PubMed ID: 12653688
[TBL] [Abstract][Full Text] [Related]
39. Differential expression of the angiogenic Tie receptor family in arthritic and normal synovial tissue.
Shahrara S; Volin MV; Connors MA; Haines GK; Koch AE
Arthritis Res; 2002; 4(3):201-8. PubMed ID: 12010571
[TBL] [Abstract][Full Text] [Related]
40. Expression of Tie1, Tie2, and angiopoietins 1, 2, and 4 in Kaposi's sarcoma and cutaneous angiosarcoma.
Brown LF; Dezube BJ; Tognazzi K; Dvorak HF; Yancopoulos GD
Am J Pathol; 2000 Jun; 156(6):2179-83. PubMed ID: 10854238
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
